Paul Newell, MD
AstraZeneca
4
0
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Mathews, MD
Quintiles, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Mark Yen, MD
PAREXEL Early Phase/California Clinical Trials Medical Group
Shared therapeutic areas:
Worked with same sponsors:
Mirjana Kujacic, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Leonard Siew, MBCHB, MRCP(UK)
Quintiles Phase I unit London
Shared therapeutic areas:
Worked with same sponsors:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Waqar ahmed awan, Phd
Riphah International University
Shared therapeutic areas:
David Meeker, MD
Rhythm Pharmaceuticals, Inc.
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
Ahmed Elshafeey, Ph.D. Pharma
Genuine Research Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers
A Study to Assess the Safety, Tolerability and Pharmacokinetics of NXL104 Alone and in Combination With Ceftazidime Administered as Single and Repeated Intravenous Doses in Healthy Japanese Subjects
Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]NXL104
All 4 trials loaded